Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 44, Pages 5241-5252
Publisher
Springer Nature
Online
2012-12-04
DOI
10.1038/onc.2012.549
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- (Z)-2-(2-Bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): An Orally Bioavailable PPARβ/δ-Selective Ligand with Inverse Agonistic Properties
- (2012) Sonja Lieber et al. JOURNAL OF MEDICINAL CHEMISTRY
- Emerging Roles of Angiopoietin-like 4 in Human Cancer
- (2012) Ming Jie Tan et al. MOLECULAR CANCER RESEARCH
- Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer
- (2011) Monica Mannelqvist et al. AMERICAN JOURNAL OF PATHOLOGY
- Angiopoietin-like 4: a decade of research
- (2011) Pengcheng Zhu et al. BIOSCIENCE REPORTS
- ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters
- (2011) R.-L. Huang et al. BLOOD
- Angiopoietin-like 4 Protein Elevates the Prosurvival Intracellular O2−:H2O2 Ratio and Confers Anoikis Resistance to Tumors
- (2011) Pengcheng Zhu et al. CANCER CELL
- Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes
- (2011) Michael G. Borland et al. CELLULAR SIGNALLING
- Development of Improved PPARβ/δ Inhibitors
- (2011) Philipp M. Toth et al. ChemMedChem
- Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin β1 signaling in human hepatocellular carcinoma
- (2011) Hong Li et al. HEPATOLOGY
- Proteolytic Processing of Angiopoietin-like Protein 4 by Proprotein Convertases Modulates Its Inhibitory Effects on Lipoprotein Lipase Activity
- (2011) Xia Lei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis
- (2011) Nakayama ONCOLOGY REPORTS
- Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ)
- (2011) Till Adhikary et al. PLoS One
- New insights into the role of PPARs
- (2011) Alexandra Montagner et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Angiopoietin-Like 4 Interacts with Integrins β1 and β5 to Modulate Keratinocyte Migration
- (2010) Yan Yih Goh et al. AMERICAN JOURNAL OF PATHOLOGY
- Angiopoietin-like 4 Interacts with Matrix Proteins to Modulate Wound Healing
- (2010) Yan Yih Goh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Transcriptional Profiling Identifies Functional Interactions of TGFβ and PPARβ/δ Signaling
- (2010) Kerstin Kaddatz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist
- (2010) Barry G. Shearer et al. JOURNAL OF MEDICINAL CHEMISTRY
- GREAT improves functional interpretation of cis-regulatory regions
- (2010) Cory Y McLean et al. NATURE BIOTECHNOLOGY
- Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling
- (2010) Josefine Stockert et al. NUCLEIC ACIDS RESEARCH
- Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion
- (2010) Nakayama ONCOLOGY REPORTS
- Determination of Angptl4 mRNA as a Diagnostic Marker of Primary and Metastatic Clear Cell Renal-Cell Carcinoma
- (2010) Jérôme Verine et al. PLoS One
- Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK Signaling
- (2010) Jun Du et al. PLoS One
- A compact VEGF signature associated with distant metastases and poor outcomes
- (2009) Zhiyuan Hu et al. BMC Medicine
- Activating Peroxisome Proliferator-Activated Receptor Mutant Promotes Tumor Growth In vivo by Enhancing Angiogenesis
- (2009) L. Tian et al. CANCER RESEARCH
- Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride Metabolism
- (2009) Suneil K. Koliwad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production
- (2008) Olga Gealekman et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Suppression of the Raf/MEK/ERK Signaling Cascade and Inhibition of Angiogenesis by the Carboxyl Terminus of Angiopoietin-Like Protein 4
- (2008) Ying-Hua Yang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PPARδ agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle
- (2008) Hyun-Joung Lim et al. ATHEROSCLEROSIS
- Acquisition of anoikis resistance reveals a synoikis-like survival style in BEL7402 hepatoma cells
- (2008) Zhiyong Zhang et al. CANCER LETTERS
- TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
- (2008) David Padua et al. CELL
- Ligand-Mediated Regulation of Peroxisome Proliferator-Activated Receptor (PPAR) / : A Comparative Analysis of PPAR-Selective Agonists and All-trans Retinoic Acid
- (2008) M. Rieck et al. MOLECULAR PHARMACOLOGY
- Macrophages, PPARs, and Cancer
- (2008) Jo A. Van Ginderachter et al. PPAR Research
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started